Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-24 @ 10:41 PM
NCT ID: NCT05397535
Eligibility Criteria: Inclusion Criteria: * Age 40 years or older; * Systolic blood pressure (SBP) \<140 mmHg and diastolic blood pressure (DBP) \<90 mmHg * SBP 130-139 mmHg, and/or DBP 85-89 mmHg Exclusion Criteria: * Diagnosis of hypertension (SBP≥140 mmHg, and/or DBP ≥90mmHg) * History of cardiovascular diseases, such as coronary heart disease, heart failure, stroke, and peripheral vascular disease * Diagnosis of chronic kidney disease, primary aldosteronism, Cushing's syndrome, or pheochromocytoma * Newly diagnosed cancer or cancer metastasis within 5 years * History of autoimmune disease * Having taken antihypertensive drugs or immunoregulators within 2 weeks * A long-term need for antihypertensive drugs or immunomoregulators * Unable to maintain moderate intensity exercise due to illness or other reasons * Pregnant, breastfeeding, or planning to become pregnant within the next 1 year * Currently taking regular exercise (at least 30 minutes of moderate-intensity exercise at least three times a week) * Allergic to sports bracelets * Having participated or been participating in other clinical trials within the last 3 months * Unable to use smartphones * Other factors that may affect the follow-up, such as alcohol or substance abuse in the last 12 months, planing to live out of town for a long time, or diagnosis of dementia or cognitive impairment which indicates incapability of completing the study * Unable to accurately measure blood pressure using the sphygmomanometer provided by the study due to a too large or too small arm circumference
Healthy Volunteers: True
Sex: ALL
Minimum Age: 40 Years
Study: NCT05397535
Study Brief:
Protocol Section: NCT05397535